ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough lung cancer in major trial
Disease control Recruiting nowThis study is testing two experimental drugs, ubamatamab and REGN7075, for people with advanced non-small cell lung cancer that has spread and has not responded well to standard treatments. The main goal is to see if these drugs can shrink tumors and control the cancer. Researche…
Matched conditions: ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for advanced lung cancer patients in pfizer trial
Disease control Recruiting nowThis study is testing a new drug, PF-08634404, when used alongside other cancer medicines in adults with advanced non-small cell lung cancer that has spread. The main goals are to see if the drug combinations are safe and if they can help control the cancer. The study is in early…
Matched conditions: ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC